Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
Naoyoshi Nagata(Tokyo Medical University), Tadashi Takeuchi(RIKEN Center for Integrative Medical Sciences), Hiroaki Masuoka(RIKEN Center for Integrative Medical Sciences), Ryo Aoki(Ezaki Glico (Japan)), Masahiro Ishikane(National Center for Global Health and Medicine), Noriko Iwamoto(National Center for Global Health and Medicine), Masaya Sugiyama(National Center for Global Health and Medicine), Wataru Suda(RIKEN Center for Integrative Medical Sciences), Yumiko Nakanishi(RIKEN Center for Integrative Medical Sciences), Junko Terada-Hirashima(National Center for Global Health and Medicine), Moto Kimura(National Center for Global Health and Medicine), Tomohiko Nishijima(Ezaki Glico (Japan)), Hiroshi Inooka(Ezaki Glico (Japan)), Tohru Miyoshi‐Akiyama(National Center for Global Health and Medicine), Yasushi Kojima(National Center for Global Health and Medicine), Chikako Shimokawa(National Institute of Infectious Diseases), Hajime Hisaeda(National Institute of Infectious Diseases), Fen Zhang(Chinese University of Hong Kong), Yun Kit Yeoh(Chinese University of Hong Kong), Siew C. Ng(Chinese University of Hong Kong), Naomi Uemura(Tokyo Medical University), Takao Itoi(Tokyo Medical University), Masashi Mizokami(National Center for Global Health and Medicine), Takashi Kawai(Tokyo Medical University), Haruhito Sugiyama(National Center for Global Health and Medicine), Norio Ohmagari(National Center for Global Health and Medicine), Hiroshi Ohno(RIKEN Center for Integrative Medical Sciences)
Cited by 144Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis